# Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation

> **NCT01371656** · PHASE3 · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 624 (actual)

## Conditions studied

- Acute Leukemias of Ambiguous Lineage
- Bacterial Infection
- Diarrhea
- Fungal Infection
- Musculoskeletal Complications
- Neutropenia
- Recurrent Childhood Acute Lymphoblastic Leukemia
- Recurrent Childhood Acute Myeloid Leukemia
- Secondary Acute Myeloid Leukemia
- Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies

## Interventions

- **DRUG:** levofloxacin

## Key facts

- **NCT ID:** NCT01371656
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 624 (ACTUAL)
- **Last updated:** 2020-12-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01371656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01371656, "Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01371656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*